Literature DB >> 32350807

Lymphoma Mimicking Chronic Active Epstein-Barr Virus: A Case Report.

Rohini Bahethi1, Mingyang Gray2, Christian Salib3, Ilya Likhterov1.   

Abstract

Epstein-Barr virus (EBV) is the main cause of infectious mononucleosis (IM), a self-limiting infection among immunocompetent patients. EBV is also implicated in the development of several malignancies. We describe a case of a previously healthy 34-year-old man who presented with non-tender, enlarging, right cervical lymphadenopathy for over a year that was associated with significant weight loss, fevers, and night sweats. Two fine needle core biopsies showed inconclusive then reactive tissue, respectively. A third excisional biopsy demonstrated a reactive lymph node with EBV-positive IM. There was no evidence of lymphoma by histologic examination or flow cytometry. A diagnosis of chronic active EBV (CAEBV) was rendered. Subsequent lymph node debulking six months later showed classic Hodgkin lymphoma (CHL) positive for EBV. The patient underwent chemotherapy with full treatment response. This is an unusual presentation of EBV infection that led to either a delayed onset or delayed diagnosis of CHL.

Entities:  

Year:  2020        PMID: 32350807      PMCID: PMC7669935          DOI: 10.1007/s12105-020-01154-y

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  16 in total

Review 1.  Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.

Authors:  Motohiko Okano
Journal:  Crit Rev Oncol Hematol       Date:  2002-12       Impact factor: 6.312

2.  Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

Authors:  Ayako Arai; Ken-Ichi Imadome; Yuko Watanabe; Mayumi Yoshimori; Takatoshi Koyama; Takeharu Kawaguchi; Chiaki Nakaseko; Shigeyoshi Fujiwara; Osamu Miura
Journal:  Int J Hematol       Date:  2011-04-14       Impact factor: 2.490

Review 3.  Hodgkin lymphoma: Pathology and biology.

Authors:  Stephan Mathas; Sylvia Hartmann; Ralf Küppers
Journal:  Semin Hematol       Date:  2016-05-13       Impact factor: 3.851

Review 4.  How we treat chronic active Epstein-Barr virus infection.

Authors:  Akihisa Sawada; Masami Inoue; Keisei Kawa
Journal:  Int J Hematol       Date:  2017-02-16       Impact factor: 2.490

Review 5.  Human leukocyte antigens and genetic susceptibility to lymphoma.

Authors:  K A McAulay; R F Jarrett
Journal:  Tissue Antigens       Date:  2015-08

Review 6.  Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.

Authors:  Aaron Auerbach; Nadine S Aguilera
Journal:  Semin Diagn Pathol       Date:  2015-02-07       Impact factor: 3.464

Review 7.  Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.

Authors:  Sanghui Park; Young H Ko
Journal:  J Dermatol       Date:  2014-01       Impact factor: 4.005

Review 8.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 9.  Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation.

Authors:  Alfred L Weber; Aliyah Rahemtullah; Judith A Ferry
Journal:  Neuroimaging Clin N Am       Date:  2003-08       Impact factor: 2.264

10.  How I treat T-cell chronic active Epstein-Barr virus disease.

Authors:  Catherine M Bollard; Jeffrey I Cohen
Journal:  Blood       Date:  2018-04-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.